News


SRI biosciences wins $100 million for radiation research

 

One hundred million dollars over five years. That's how much the SRI International biosciences division is being awarded as part of a contract to research and develop products to address the effects of radiation exposure.

The multi-year contract was awarded by the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health.

The principal investigator for the contract will be Polly Chang, senior director of molecular and genetic toxicology at SRI Biosciences. The award will support work related to developing medical "countermeasures" to address the effects of radiation and nuclear exposure.

SRI International is based in Menlo Park.

Kate Bradshaw

Comments

Sorry, but further commenting on this topic has been closed.

Palo Alto Measures E, F and Z
By Steve Levy | 5 comments | 1,452 views

Menlo Park Council Selections for 2018
By Stuart Soffer | 6 comments | 1,222 views

Couples: It's Normal to Get Defensive . . . Then What?
By Chandrama Anderson | 0 comments | 922 views

Messiness and parenting
By Cheryl Bac | 2 comments | 710 views

Learning Disabilities and the Struggle to Be Known
By Aldis Petriceks | 0 comments | 286 views